The potential coronavirus vaccine, developed by a top Chinese military virologist has shown effective results in early clinical trials. A single dose of the vaccine has been able to produce effective antibodies in the human body within 14 days.
Preliminary trials of the vaccine have developed immunity in hundreds of healthy adults. The vaccine has been able to successfully produce antibodies in the human body.
According to local Chinese media on Saturday (May 23), the first phase of testing of the vaccine, developed by the Academy of Military Medical Sciences and the Chinese company Cancino Bio, suggested the vaccine was completely safe.
These results represent an important milestone, said Major General Chen Wei, a scientist leading military researchers, in a statement.
Tests have shown that a single dose of the vaccine produces antibodies against a specific virus within 14 days. We are moving towards a larger trial to make it more precise.
The second phase of the recombinant adenovirus vector-based vaccine trial, developed by the People's Liberation Army Academy of Military Medical Sciences and the Chinese company Cancino Bio, began on April 12. The vector vaccine is safe and capable of eradicating many diseases at once. The vaccine is able to prevent coronavirus proteins and bring the body's immunity home. It has no side effects.